| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 3131-03-1 | Pristinamycin IA (9CI); OstreogrycinB (6CI,7CI); virginiamycin S1, 4-[4-(dimethylamino)-N-methyl-L-phenylalanine]-; 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Antibiotic PA 114B; Antibiotic PA 114B1; Glycine,N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-2-aminobutanoyl-L-prolyl-4-(dimethylamino)-N-methyl-L-phenylalanyl-4-oxo-L-2-piperidinecarbonyl-L-2-phenyl-,r-lactone; Mikamycin B; MikamycinIA; NSC 92554; PA 114B; Pristinamycin P 1; Streptogramin B; Vernamycin Ba |  | C45H54N8O10 | 详情 | 供应商 | |
| 28979-74-0 | Pristinamycin IC(8CI,9CI); OstreogrycinB1 (7CI); virginiamycin S1,2-D-alanine-4-[4-(dimethylamino)-N-methyl-L-phenylalanine]-; 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Glycine,N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-alanyl-L-prolyl-4-(dimethylamino)-N-methyl-L-phenylalanyl-4-oxo-L-pipecoloyl-L-2-phenyl-,r-lactone; Vernamycin Bg |  | C44H52N8O10 | 详情 | 供应商 | |
| 57206-54-9 | Pristinamycin IB (9CI); OstreogrycinB2 (7CI); virginiamycin S1, 4-[N-methyl-4-(methylamino)-L-phenylalanine]-; 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Efepristin; Glycine,N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-a-aminobutyryl-L-prolyl-N-methyl-4-(methylamino)-L-phenylalanyl-4-oxo-L-pipecoloyl-L-2-phenyl-,r-lactone; Vernamycin Bb |  | C44H52N8O10 | 详情 | 供应商 | |
| 26549-61-1 | virginiamycin S1,5-[(2S)-4-hydroxy-2-piperidinecarboxylic acid]- (9CI); StaphylomycinS, 5-(4-hydroxy-L-pipecolic acid)- (8CI); virginiamycin S1, 5-(4-hydroxy-L-2-piperidinecarboxylicacid)-; 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Dihydrostaphylomycin S; Dihydrovirginiamycin S1; virginiamycin S1, dihydro- |  | C43H51N7O10 | 详情 | 供应商 | |
| 23152-29-6 | virginiamycin S1; StaphylomycinS (6CI,7CI,8CI); 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Antibiotic 1754Z3B; Factor S; Factor S (antibiotic); Glycine,N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-2-aminobutanoyl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-2-piperidinecarbonyl-L-2-phenyl-,r-lactone; N-[(3-Hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-2-aminobutanoyl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-2-piperidinecarbonyl-L-2-phenylglyciner-lactone; Staphylomycin S1 |  | C43H49N7O10 | 详情 | 供应商 | |
| 33477-37-1 | virginiamycin S4 (9CI); virginiamycinS1, 2-D-alanine-; 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Glycine,N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-alanyl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-2-piperidinecarbonyl-L-2-phenyl-,r-lactone; Staphylomycin S4 |  | C42H49N7O10 | 详情 | 供应商 | |
| 14014-70-1 | Vernamycin C (8CI,9CI); Doricin(7CI); virginiamycin S1, 4-[4-(dimethylamino)-N-methyl-L-phenylalanine]-5-L-asparticacid-; Pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine, cyclic peptidederiv.; Glycine,N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-2-aminobutanoyl-L-prolyl-4-(dimethylamino)-N-methyl-L-phenylalanyl-L-a-aspartyl-L-2-phenyl-, r-lactone |  | C43H52N8O11 | 详情 | 供应商 | |
| 33477-39-3 | virginiamycin S1,5-[(2S)-5-hydroxy-4-oxo-2-piperidinecarboxylic acid]-; virginiamycinS1, 5-(5-hydroxy-4-oxo-L-2-piperidinecarboxylic acid)-; virginiamycin S3(8CI,9CI); 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Staphylomycin S3 |  | C43H49N7O11 | 详情 | 供应商 |
